Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 244 participants.

Also called NCT01651156

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 244 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01651156
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01651156. Randomized; quadruple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2013-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema
Condition
Cardiac Edema
Intervention (Drug)
Tolvaptan
Intervention (Drug)
Placebo
Lead sponsor
Otsuka Beijing Research Institute (class: industry)

Record details

Record id
cardio:ct-nct01651156
Content hash
244d7c17bac0ca5f0b7b7b3d974944432b3c8ed92d42e420e0dd19fbcd55ac22